Metrics
Figures converted from CHF to USD at historical FX rates (frankfurter.app). Monetary statements are shown in US$ millions; per-share figures use the matching period rate. Filing links open the native figures from which each USD value was derived.
The numbers behind Sonova Holding AG: as-reported financial statements and company metrics for FY2022–FY2026, traced to the source filings, opened with the share-price history those statements have to justify. Every linked USD figure opens the exact filing row containing the native reported value from which it was converted. Amounts in US$ millions unless noted.
Reading notes: Reporting currency is CHF; all figures are in CHF million exactly as printed in the consolidated statements. Sonova's fiscal year ends 31 March; FY labels use the ending calendar year (FY2026 = financial year 2025/26). Each fiscal year in the main columns is cited to that year's own Annual Report (e.g. FY2026 = Annual Report 2025/26). Balance-sheet and cash-flow comparatives were cross-checked against the following year's report. FY2026 (2025/26) is presented on a continuing-operations basis after Consumer Hearing was classified as a discontinued operation (IFRS 5, announced 23 March 2026). Revenue and operating lines therefore step down between FY2025 and FY2026; net income and diluted EPS are stated on a total (incl. discontinued) basis throughout and remain comparable. Segment 'Sales' rows are external sales from Note 2.2; the revenue total ties to the Consolidated income statement 'Sales' line.
Share Price — Available History Since January 2026
The stock closed at $256.64 on Jul 23, 2026 — down 7% over the window shown, trading between $210.16 and $275.88. At that close the stock trades at 28× FY2026 diluted EPS as reported below.
Source: market price feed, daily closes, Jan 2026–Jul 2026 — the feed marks this available history as partial. Price return only, excludes dividends. Prices converted from CHF to USD with date-matched or nearest-available FX.
FY2026 at a Glance
Operating income (US$ millions)
Diluted EPS
Source: FY2026 consolidated statements [1] [2] [3] [4]. Click any linked figure to open the filing page with the row highlighted.
Sales by Segment
| Sales by Segment | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Hearing Instruments | 3,334 | 3,766 | 3,706 | 4,041 | 4,194 |
| Cochlear Implants | 303 | 313 | 309 | 345 | 315 |
| Sales | 3,637 | 4,079 | 4,015 | 4,386 | 4,510 |
Source: Note 2.2 Segment information (external sales); total per Consolidated income statement [5] [1] [6] [2]. Click any linked figure to open the filing page with the row highlighted.
Segment Profit (EBITA)
| Segment Profit (EBITA) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Hearing Instruments | 846 | 842 | 777 | 819 | 949 |
| Cochlear Implants | 21 | 33 | 28 | 32 | (43) |
| Total (EBITA) | 868 | 875 | 805 | 851 | 906 |
Source: Note 2.2 Segment information — operating profit before acquisition-related amortization (EBITA) [5] [6] [7] [8]. Click any linked figure to open the filing page with the row highlighted.
Income Statement
| Income Statement | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | FY2027E |
|---|---|---|---|---|---|---|
| Sales | 3,637 | 4,079 | 4,015 | 4,386 | 4,510 | — |
| Cost of sales | (977) | (1,201) | (1,125) | (1,226) | (1,185) | — |
| Gross profit | 2,661 | 2,877 | 2,890 | 3,160 | 3,324 | — |
| Research and development | (249) | (267) | (265) | (267) | (272) | — |
| Sales and marketing | (1,230) | (1,436) | (1,490) | (1,662) | (1,671) | — |
| General and administration | (347) | (360) | (393) | (445) | (509) | — |
| Operating profit (EBIT) | 822 | 815 | 742 | 785 | 845 | — |
| Income before taxes | 787 | 781 | 717 | 740 | 803 | — |
| Income taxes | (70) | (63) | (42) | (119) | (120) | — |
| Loss after tax from discontinued operations | — | — | — | — | (133) | — |
| Income after taxes | 717 | 718 | 675 | 621 | 550 | — |
| Basic earnings per share | 11.27 | 11.73 | 11.16 | 10.29 | 9.04 | — |
| Diluted earnings per share | 11.19 | 11.70 | 11.13 | 10.26 | 9.03 | 13.97 |
Source: Consolidated income statement [1] [2] [3] [4]. Click any linked figure to open the filing page with the row highlighted.
Columns marked E are consensus analyst estimates from analyst consensus, shown alongside reported results for direct comparison; they are not company guidance.
Estimate source: analyst consensus (claude_web), as of 2026-07-23. Forecasts carry no filing page links.
Balance Sheet
| Balance Sheet | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 660 | 452 | 569 | 779 | 903 |
| Trade receivables | 513 | 572 | 596 | 655 | 659 |
| Inventories | 446 | 457 | 482 | 532 | 476 |
| Total current assets | 1,794 | 1,651 | 1,829 | 2,169 | 2,606 |
| Property, plant and equipment | 388 | 405 | 421 | 431 | 452 |
| Intangible assets and goodwill | 3,188 | 3,336 | 3,364 | 3,387 | 3,278 |
| Total assets | 6,042 | 6,058 | 6,412 | 6,722 | 7,039 |
| Current financial liabilities | 405 | 24 | 21 | 424 | 152 |
| Total current liabilities | 1,628 | 1,205 | 1,260 | 1,702 | 1,486 |
| Non-current financial liabilities | 1,038 | 1,736 | 1,745 | 1,368 | 1,695 |
| Total liabilities | 3,412 | 3,623 | 3,654 | 3,676 | 3,743 |
| Equity | 2,630 | 2,434 | 2,758 | 3,046 | 3,296 |
Source: Consolidated balance sheet (as at 31 March) [9] [10] [11] [12]. Click any linked figure to open the filing page with the row highlighted.
Cash Flow
| Cash Flow | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Cash flow from operating activities | 1,018 | 855 | 834 | 901 | 885 |
| Purchase of tangible and intangible assets | (115) | (168) | (142) | — | — |
| Purchase of property, plant and equipment | — | — | — | (102) | (102) |
| Purchase of intangible assets | — | — | — | (54) | (27) |
| Cash consideration for acquisitions, net of cash acquired | (642) | (285) | (112) | (88) | (57) |
| Cash flow from investing activities | (763) | (467) | (259) | (241) | (240) |
| Share buyback program | (733) | (487) | — | — | — |
| Purchase of treasury shares | (86) | (62) | (57) | (76) | (79) |
| Dividends paid to shareholders of Sonova Holding AG | (218) | (292) | (303) | (291) | (328) |
| Cash flow from financing activities | (1,505) | (595) | (460) | (456) | (566) |
| Increase in cash and cash equivalents | (1,256) | (214) | 110 | 197 | 65 |
| Free cash flow, derived | — | — | — | 799 | 783 |
Source: Consolidated cash flow statement [13] [14] [15] [16]. Click any linked figure to open the filing page with the row highlighted.
Long-Term Record
| Fiscal year | Total revenue | Operating profit (EBIT) | Net income | Diluted earnings per share | Operating cash flow |
|---|---|---|---|---|---|
| FY2017 | 2,395 | 424 | 356 | 5.34 | 522 |
| FY2018 | 2,768 | 505 | 426 | 6.39 | 547 |
| FY2019 | 2,776 | 539 | 462 | 6.98 | 536 |
| FY2020 | 3,019 | 528 | 507 | 7.83 | 873 |
| FY2021 | 2,756 | 656 | 620 | 9.73 | 810 |
| FY2022 | 3,637 | 822 | 717 | 11.19 | 1,018 |
| FY2023 | 4,079 | 815 | 718 | 11.70 | 855 |
| FY2024 | 4,015 | 742 | 675 | 11.13 | 834 |
| FY2025 | 4,386 | 785 | 621 | 10.26 | 901 |
| FY2026 | 4,510 | 845 | 550 | 9.03 | 885 |
Source: consolidated statements across filings; older years from the standardized feed [13] [1] [14] [2]. Click any linked figure to open the filing page with the row highlighted.
Analyst Consensus
Street ratings: Consensus rating: Hold / Neutral, tilted cautious (more sell than buy ratings). valueinvesting.io: Hold from 28 analysts (2 strong buy, 3 buy, 11 hold, 9 sell, 3 strong sell), mean target CHF 238.81 (range 185.84–378.00). TipRanks: 'Moderate Sell', 12 analysts, average target CHF 228.64 (high 294, low 190). Stockopedia/MarketScreener: Hold, target CHF ~206–208. Reported mean of 228.64 CHF is the TipRanks 12-analyst average; cross-aggregator targets span roughly CHF 206–239. Currency: CHF.
Estimate source: analyst consensus (claude_web), as of 2026-07-23. Forecasts carry no filing page links.
Traceability
220 of 245 figures on this page (90%) link to the filing page containing the native reported figure from which the USD value was converted — click a linked figure to open that source row. Unlinked figures come from standardized data feeds or pre-filing years.
Reporting currency is CHF; all figures are in CHF million exactly as printed in the consolidated statements. Sonova's fiscal year ends 31 March; FY labels use the ending calendar year (FY2026 = financial year 2025/26).
Each fiscal year in the main columns is cited to that year's own Annual Report (e.g. FY2026 = Annual Report 2025/26). Balance-sheet and cash-flow comparatives were cross-checked against the following year's report.
FY2026 (2025/26) is presented on a continuing-operations basis after Consumer Hearing was classified as a discontinued operation (IFRS 5, announced 23 March 2026). Revenue and operating lines therefore step down between FY2025 and FY2026; net income and diluted EPS are stated on a total (incl. discontinued) basis throughout and remain comparable.
Segment 'Sales' rows are external sales from Note 2.2; the revenue total ties to the Consolidated income statement 'Sales' line.
Long-term record FY2017-FY2021 figures are from the standardized data feed and are shown without page links; FY2022-FY2026 are cited to the annual reports.
No quarterly block: Sonova reports semi-annually (half-year and full-year), not quarterly, so the renderer's numeric-feed fallback is used for any interim view.
3 figure(s) differed between the data feed and the filing; the filing value is shown (see the run's metrics/metrics_tab.json for the audit trail).